Wells Fargo & Company Cv Rx, Inc. Call Options Transaction History
Wells Fargo & Company
- $434 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CVRX
# of Institutions
86Shares Held
14.4MCall Options Held
56.3KPut Options Held
41.8K-
Johnson & Johnson New Brunswick, NJ4.1MShares$55.4 Million11.52% of portfolio
-
Nea Management Company, LLC Timonium, MD2.37MShares$32 Million1.6% of portfolio
-
Black Rock Inc. New York, NY876KShares$11.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA824KShares$11.1 Million0.0% of portfolio
-
Parkman Healthcare Partners LLC Stamford, CT683KShares$9.22 Million0.85% of portfolio
About CVRx, Inc.
- Ticker CVRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 20,576,200
- Market Cap $278M
- Description
- CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...